These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2185492)

  • 1. Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine.
    Ryffel B
    Pharmacol Rev; 1990 Sep; 41(3):407-22. PubMed ID: 2185492
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
    Granelli-Piperno A; Keane M
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.
    Hess AD; Esa AH; Colombani PM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):29-40. PubMed ID: 2834840
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex.
    Schlitt HJ; Schwinzer R; Kurrle R; Wonigeit K
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):103-9. PubMed ID: 2966472
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicardipine enhances the effect of cyclosporine A on T lymphocyte activation in vitro.
    van Eendenburg JP; Brisson E; Klatzmann D; Gluckman JC
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):245-52. PubMed ID: 3129843
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
    Fahr A; Hiestand P; Ryffel B
    Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine action in blockade of cellular immune responses.
    Lorber MI
    Year Immunol; 1986; 2():279-88. PubMed ID: 3554824
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cyclosporine A on early stages of T cell activation.
    Isakov N; Scholz W; Altman A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1186-8. PubMed ID: 3493569
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of cyclosporine A on humoral and cellular immunity in insulin-dependent (type I) diabetes mellitus.
    Boitard C; Debray-Sachs M; Chatenoud L; Bach JF
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):193-6. PubMed ID: 3289205
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine metabolites suppress T cell proliferation induced by concanavalin A.
    Dindzans VJ; Wong PY; Mee AV; Cheung F; Abecassis M; Cole EH; Cohen Z; Levy GA
    Transplant Proc; 1987 Aug; 19(4):3490-3. PubMed ID: 3303521
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine A modulates the proliferation of T-lymphocyte colony forming cell subpopulations.
    Tice DG; Reinitz ER
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1191-2. PubMed ID: 3274305
    [No Abstract]   [Full Text] [Related]  

  • 16. On the partial suppression of IL-2 receptor expression and the prevention of lectin-induced lymphoblast formation by cyclosporine A.
    Solbach W; Heeg K; Von Steldern DU; Röllinghoff M; Wagner H
    Clin Exp Immunol; 1985 Jun; 60(3):501-8. PubMed ID: 3926357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin-resistant and -sensitive T-lymphocyte subsets.
    Hess AD; Colombani PN
    Ann Inst Pasteur Immunol; 1987; 138(4):606-11. PubMed ID: 3499913
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin 1-mediated activation of interleukin 4 (IL 4)-producing T lymphocytes. Proliferation by IL 4-dependent and IL 4-independent mechanisms.
    Ho SN; Abraham RT; Nilson A; Handwerger BS; McKean DJ
    J Immunol; 1987 Sep; 139(5):1532-40. PubMed ID: 3114369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine-induced enhancement of interleukin 1 receptor expression by PHA-stimulated lymphocytes.
    Degiannis D; Stein S; Czarnecki M; Raskova J; Raska K
    Transplantation; 1990 Dec; 50(6):1074-6. PubMed ID: 2147793
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
    June CH; Ledbetter JA; Lindsten T; Thompson CB
    J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.